Dr. Lal PathLabs (BOM:539524) 5-Year EBITDA Growth Rate : 13.70% (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs 5-Year EBITDA Growth Rate?

Dr. Lal PathLabs's EBITDA per Share for the three months ended in Sep. 2024 was ₹26.89.

During the past 12 months, Dr. Lal PathLabs's average EBITDA Per Share Growth Rate was 20.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 11.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 16.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Dr. Lal PathLabs was 35.40% per year. The lowest was 9.80% per year. And the median was 20.70% per year.

Competitive Comparison of Dr. Lal PathLabs's 5-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr. Lal PathLabs's 5-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's 5-Year EBITDA Growth Rate falls into.

Dr. Lal PathLabs 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Dr. Lal PathLabs (BOM:539524) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Dr. Lal PathLabs 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr. Lal PathLabs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (BOM:539524) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

LALPATHLAB:India

Address

12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001

Website

https://www.lalpathlabs.com

Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs Headlines

No Headlines